Sign up
Pharma Capital
EPIC: RIR
Market: TSX-V
52-week High/Low: C$0.25 / C$0.05
Sector: Medical Cannabis
Market Cap: C$0.73M
Website: indiva.ca

INDIVA is a Canadian supplier of high quality, medical grade cannabis. INDIVA’s strain selection, cultivation and client care processes combine the know-how and experience of an internationally recognized and award winning grow-team with GMP-compliant quality assurance standard operating procedures.

INDIVA Ltd

indiva.ca

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in INDIVA Ltd

Lithium_381225958.jpg
Rainmaker Resources may have been conspicuous by its absence from news feeds for a few months and its shares may be towards the bottom of its historical range, but investments are made of far more than that
View full RIR profile View Profile
View All

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.